Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients

Abstract

The major advantage of our analysis is that we evaluated all genes in the same set of patients thereby making direct comparison of the markers feasible. The best performing genes include BIRC5, CASP3, CTNNB1, TIMP-1, MMP-2, SIRT, and VEGF.